Killian Meara

The statement says the agency is talking with CMS to initiate new flexibilities, but multiple advocacy groups have said it’s not nearly enough.

Clobetasol propionate ophthalmic suspension 0.05% is the first ophthalmic clobetasol propionate product approved by the FDA and is the first new ophthalmic steroid on the market in over 15 years.

Viking Therapeutics’ VK2735 met both of its primary and secondary endpoints in the VENTURE trial, demonstrating statistically significant reductions in body weight compared to placebo.

Analysis of participants who never used tobacco cigarettes showed that daily cannabis use was associated a higher risk of both heart attack and stroke.

Reese Pharmaceutical’s ColoTest has a suggested retail price of $19.99 and will also be sold on major retail shelves later this spring.

Participants of a recent study who received automated text messaging and monitoring, as well as peer support and coaching, increased PrEP uptake from 11% to over 20%.

Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed during a session at Outcomes 2024 SYNC National Conference several specific opportunities at the pharmacists disposal.

Nicole Bernabe, CPhT, customer success specialist at TelePharm, discusses how the company is helping pharmacies increase operational efficiency while providing care to patients in need.

During a session at the Outcomes 2024 SYNC National Conference, Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed the impacts that advancements in technology have had on pharmacy.

Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed how technological solutions can aid pharmacies during a session at the Outcomes 2024 SYNC National Conference in Orlando, Florida.

The approval was based on positive data from a phase 3 trial that showed patients treated with omalizumab were significantly more likely to tolerate peanut, milk, egg, or cashew protein without moderate to severe allergic symptoms.

As pharmacies continue their rapid adoption of technological tools to improve efficiency, being prepared for cyberattacks is more important than ever.

Drug Topics sat down with Jude Dieterman, CEO of Outcomes, to discuss the value and uniqueness of the company in the pharmacy market, what’s next on the horizon, and the upcoming event.

Mental health challenges in the United States were exacerbated by the COVID-19 pandemic, and pharmacists are poised to help pick up the pieces.

After myocardial infarction, all-cause mortality was the most frequent event, followed by heart failure, renal failure, and atrial fibrillation.

A new study found that opioid morphine milligram equivalents dose prescribed in the 60 days prior to delivery date was significantly associated with a higher likelihood of spontaneous preterm birth.

Participants of a recent study who experienced more daily cognitive symptoms had a greater likelihood of reporting moderate interference with functioning, less likelihood of full-time employment, and greater severity of depressive symptoms.

Many patients with the condition continue to experience severe hypoglycemic events even with the use of continuous glucose monitors and other disease management tools.

Drug Topics talked with Gregg Sylvester, MD, chief health officer and vice president of medical affairs at CSL Seqirus, about what we can learn from this unique situation to improve future vaccine development and distribution.

The NDA submitted by Lykos Therapeutics was assigned a Prescription Drug User Fee Act date of August 11, 2024.

A new study found that 52% of participants with treatment-refractory unipolar or bipolar depression achieved remission after 3 ketamine infusions.

The link between high-risk human papillomavirus infection and atherosclerotic cardiovascular disease mortality was strongest in women with obesity.

In terms of geographic representation, nonmetropolitan counties, the West, and the South had higher excess deaths than reported COVID-19 deaths.

A new study found that over a quarter of participants with type 1 daiebets exhibited clinically relevant levels of posttraumatic stress symptoms related to a diabetes event that they experienced.

Participants of a recent study who had pre-existing depression or anxiety were significantly more likely to develop insomnia.

Investigators found that the non-pharmacological interventions were significantly effective at improving HbA1c, quality of life, anxiety, and blood glucose.

A new study found that Hispanic patients were more likely to report fair or poor health and reduced activity compared to non-Hispanic patients at 3 months.

A recent study found that patients with pre-gestational diabetes reported higher levels of both borderline and abnormal anxiety compared to patients with gestational diabetes.

Findings from a recent study showed that participants who watched a video discussing COVID-19 vaccination had significantly higher knowledge scores compared to those who did not watch it.

Three posters being presented at the Society for Maternal-Fetal Medicine 44th Annual Pregnancy Meeting examined the impact of continuous glucose monitoring on pregnancy outcomes.